Nonviral gene delivery to human breast cancer cells by targeted Ad5 penton proteins
- 1 December 2001
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 8 (23) , 1753-1761
- https://doi.org/10.1038/sj.gt.3301583
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 32 references indexed in Scilit:
- 3PO, a novel nonviral gene delivery system using engineered Ad5 penton proteinsGene Therapy, 2001
- Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors.Journal of Clinical Investigation, 1997
- Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5Science, 1997
- The transmembrane domain of diphtheria toxin improves molecular conjugate gene transferBiochemical Journal, 1997
- Target Cell-specific DNA Transfer Mediated by a Chimeric Multidomain ProteinJournal of Biological Chemistry, 1996
- MHC class I-cestricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenovirusesImmunity, 1994
- Stepwise dismantling of adenovirus 2 during entry into cellsCell, 1993
- Gene therapy: adenovirus vectorsCurrent Opinion in Genetics & Development, 1993
- Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachmentCell, 1993
- Evidence that the penton base of adenovirus is involved in potentiation of toxicity of Pseudomonas exotoxin conjugated to epidermal growth factor.Molecular and Cellular Biology, 1984